Finally, factors associated with an impact on chemotherapy and HDI treatment, such as ulceration, tumor stage and the number of nodal metastases were not included in this study, which may have caused bias in the results and prevented us from verifying whether Ki67 expression can be a precise predictor of therapeutic effect. The gene discussed is MKI67; the disease is neoplasm.